Premier Anti-Aging Co., Ltd.
Notice on Differences between Consolidated Full-Year Earnings Forecast for the 2026 July Term and Actual Results
Differences occurred between the full-year consolidated earnings forecast for the 2026 July term and actual results. Net sales were higher than the previous forecast, actual result was 13,883 million yen vs. the previous forecast of 13,500 million yen. Operating income was 494 million yen, ordinary income was 602 million yen, and net income attributable to owners of parent was 364 million yen. Ordinary income benefited from foreign exchange gains. New lineups, advertising investments, and fixed-cost reductions were implemented as planned. A special loss was recognized due to dissolution of local subsidiaries.
Key Figures
- Net Sales: 13,883 million yen（Compared to previous forecast 13,500 million yen, +383 million yen）
- Operating Income: 494 million yen（Compared to previous forecast 300 million yen, +194 million yen）
- Net Income Attributable to Owners of Parent: 364 million yen（Compared to previous forecast 300 million yen, +64 million yen）
AI要約
Difference in Results
There was a difference between the full-year results forecast for the 2026 July term and actual results. Company-wide net sales reached the plan, but the aging-care segment’s new customer acquisition recovery took longer, and mail-order sales fell below last year. On the other hand, the recovery market expansion supported sales mainly in offline channels. As a result of pursuing advertising and promotional investments and fixed-cost reductions, operating income exceeded the plan, and ordinary income rose due to foreign exchange gains.
Outlook and Structural Reform
We decided to consolidate the sales structure in the China market into cross-border EC and proceeded with dissolution and liquidation of the local subsidiary. Related business-structure reform costs were recognized as special losses. Going forward, we will continue promotional activities for new lines and cost management to improve profitability.
Premier Anti-Aging Co., Ltd.
Company overview · Stock price · Financial data · All IR
